Therapeutic indications

Apomorphine is indicated for:

Treatment of motor fluctuations ("on-off" phenomena) in patients with Parkinson's disease

Population group: both men and women, only adults (18 years old or older)

Apomorphine is indicated for the treatment of motor fluctuations (‘on-off’ phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral anti-Parkinson medication.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Incremental dosing schedules according to the patient's response within the range of 3-100 mg


Apomorphine is contraindicated in the following cases:

Respiratory depression, dementia, psychotic diseases, hepatic insufficiency

at least one of
Decreased respiratory function

Respiratory insufficiency


Psychotic disorder

Hepatic insufficiency

Levodopa, severe dyskinesia or dystonia

at least one of
Diurnal dystonia